Radiation 'Bridge' tested to boost powerful Cancer-Fighting cell therapy
NCT ID NCT05800405
Summary
This early study is testing if giving targeted radiation to all visible cancer sites is a safe and practical 'bridge' treatment for patients waiting for a powerful cell therapy called CAR T-cells. It is for adults with a fast-growing type of lymphoma that has returned or hasn't responded to other treatments. The goal is to see if this approach helps control the cancer better during the critical waiting period and improves the overall results of the CAR T-cell therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.